STOCK AWARD PLANS | (7) STOCK AWARD PLANS The Company has share-based compensation plans which are described below. The compensation cost that has been charged against earnings for the Company’s stock award plans and the income tax benefit recognized in the statement of earnings for stock awards for the three months and six months ended June 30, 2017 and 2016 were as follows (in thousands): Three months ended June 30, Six months ended June 30, 2017 2016 2017 2016 Compensation cost $ 3,231 $ 2,961 $ 5,924 $ 5,545 Income tax benefit $ 1,271 $ 1,110 $ 2,152 $ 2,079 The Company has an employee stock award plan for selected officers and other key employees which provides for the issuance of stock options, restricted stock and performance awards. The exercise price for each option equals the fair market value per share of the Company’s common stock on the date of grant. Substantially all stock options outstanding under the plan have terms of seven years and vest ratably over three years. No performance awards payable in stock have been awarded under the plan. At June 30, 2017, 1,741,076 shares were available for future grants under the employee plan and no outstanding stock options under the employee plan were issued with stock appreciation rights. The following is a summary of the stock option activity under the employee plan described above for the six months ended June 30, 2017: Outstanding Non- Qualified or Nonincentive Stock Awards Weighted Average Exercise Price Outstanding at December 31, 2016 601,121 $ 65.33 Granted 121,908 $ 68.50 Exercised (16,910 ) $ 32.82 Outstanding at June 30, 2017 706,119 $ 66.66 The following table summarizes information about the Company’s outstanding and exercisable stock options under the employee plan at June 30, 2017: Options Outstanding Options Exercisable Range of Exercise Prices Number Outstanding Weighted Average Remaining Contractual Life in Years Weighted Average Exercise Price Aggregate Intrinsic Value Number Exercisable Weighted Average Exercise Price Aggregate Intrinsic Value $ 46.74 - $51.23 212,335 4.3 $ 50.03 108,531 $ 48.89 $ 64.89 - $74.99 424,643 4.5 $ 69.78 237,022 $ 70.31 $ 93.64 - $96.85 33,987 3.6 $ 94.31 33,987 $ 94.31 $ 101.46 - $104.37 35,154 3.7 $ 102.60 35,154 $ 102.60 $ 46.74 - $104.37 706,119 4.3 $ 66.66 $ 3,711,000 414,694 $ 69.41 $ 2,029,000 The following is a summary of the restricted stock award activity under the employee plan described above for the six months ended June 30, 2017: Unvested Restricted Stock Award Shares Weighted Average Grant Date Fair Value Per Share Nonvested balance at December 31, 2016 377,655 $ 66.14 Granted 125,545 $ 68.55 Vested (105,272 ) $ 68.92 Forfeited (1,017 ) $ 64.20 Nonvested balance at June 30, 2017 396,911 $ 66.17 The Company has a stock award plan for nonemployee directors of the Company which provides for the issuance of stock options and restricted stock. The director plan provides for automatic grants of restricted stock to nonemployee directors after each annual meeting of stockholders. In addition, the director plan allows for the issuance of stock options or restricted stock in lieu of cash for all or part of the annual director fee at the option of the director. The exercise prices for all options granted under the plan are equal to the fair market value per share of the Company’s common stock on the date of grant. The terms of the options are ten years. The restricted stock issued after each annual meeting of stockholders vests six months after the date of grant. Options granted and restricted stock issued in lieu of cash director fees vest in equal quarterly increments during the year to which they relate. At June 30, 2017, 510,071 shares were available for future grants under the director plan. The director stock award plan is intended as an incentive to attract and retain qualified independent directors. The following is a summary of the stock option activity under the director plan described above for the six months ended June 30, 2017: Outstanding Non- Qualified or Nonincentive Stock Options Weighted Average Exercise Price Outstanding at December 31, 2016 205,429 $ 64.60 Granted 3,188 $ 70.65 Exercised (39,000 ) $ 46.23 Forfeited (12,000 ) $ 87.35 Outstanding at June 30, 2017 157,617 $ 67.54 The following table summarizes information about the Company’s outstanding and exercisable stock options under the director plan at June 30, 2017: Options Outstanding Options Exercisable Range of Exercise Prices Number Outstanding Weighted Average Remaining Contractual Life in Years Weighted Average Exercise Price Aggregate Intrinsic Value Number Exercisable Weighted Average Exercise Price Aggregate Intrinsic Value $ 29.60 6,000 1.8 $ 29.60 6,000 $ 29.60 $ 41.24 – $56.45 53,276 2.9 $ 52.77 53,276 $ 52.77 $ 61.89 – $62.48 35,153 5.0 $ 62.31 35,153 $ 62.31 $ 70.65 – $99.52 63,188 6.5 $ 86.50 60,797 $ 87.13 $ 29.60 – $99.52 157,617 4.8 $ 67.54 $ 1,133,000 155,226 $ 67.49 $ 1,133,000 The following is a summary of the restricted stock award activity under the director plan described above for the six months ended June 30, 2017: Unvested Restricted Stock Award Shares Weighted Average Grant Date Fair Value Per Share Nonvested balance at December 31, 2016 347 $ 64.89 Granted 21,198 $ 70.65 Vested (666 ) $ 67.65 Nonvested balance at June 30, 2017 20,879 $ 70.65 The total intrinsic value of all stock options exercised under all of the Company’s plans was $1,530,000 and $266,000 for the six months ended June 30, 2017 and 2016, respectively. The actual tax benefit realized for tax deductions from stock option exercises was $555,000 and $100,000 for the six months ended June 30, 2017 and 2016, respectively. The total intrinsic value of all the restricted stock vestings under all of the Company’s plans was $7,015,000 and $5,556,000 for the six months ended June 30, 2017 and 2016, respectively. The actual tax benefit realized for tax deductions from restricted stock vestings was $2,546,000 and $2,083,000 for the six months ended June 30, 2017 and 2016, respectively. As of June 30, 2017, there was $4,631,000 of unrecognized compensation cost related to nonvested stock options and $23,554,000 related to restricted stock. The stock options are expected to be recognized over a weighted average period of approximately 1.8 years and restricted stock over approximately 3.5 years. The total fair value of options vested was $2,492,000 and $2,495,000 during the six months ended June 30, 2017 and 2016, respectively. The fair value of the restricted stock vested was $7,015,000 and $5,556,000 for the six months ended June 30, 2017 and 2016, respectively. The weighted average per share fair value of stock options granted during the six months ended June 30, 2017 and 2016 was $20.73 and $17.30, respectively. The fair value of the stock options granted during the six months ended June 30, 2017 and 2016 was $2,594,000 and $3,231,000, respectively. The Company currently uses treasury stock shares for restricted stock grants and stock option exercises. The fair value of each stock option was determined using the Black-Scholes option pricing model. The key input variables used in valuing the options during the six months ended June 30, 2017 and 2016 were as follows: Six months ended June 30, 2017 2016 Dividend yield None None Average risk-free interest rate 2.0 % 1.5 % Stock price volatility 27 % 30 % Estimated option term Six years Six years |